ADARx Pharmaceuticals plans IPO sale of 21.9M shares
ADARx Pharmaceuticals said it plans to sell nearly 21.9 million shares in its IPO at $15 to $17 each.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.